Targeted Proteomic Analysis in the Plasma of Children With Diabetes Type 1 and Its Association With Peripheral Diabetic Neuropathy

Status: Recruiting
Location: See location...
Intervention Type: Procedure
Study Type: Observational
SUMMARY

The aim of the present study is to investigate a targeted proteomic analysis in plasma of children - of Greek origin- with type 1 diabetes (DT1) and its correlation with the electrophysiological findings that accompany diabetic peripheral neuropathy. Diabetic neuropathy is the most frequent chronic complication in adults with DT1 and rarely appears in childhood. Nevertheless, cases of acute mononeuritis have been described at the time of diagnosis of DT1. According to recent reports several biomarkers, including proteomic analysis, have been proposed for the early detection of peripheral neuropathy in children and young adults with T1DM. In the present study the researchers will attempt to investigate the role of biomarkers with targeted proteomic analysis in the plasma of children with DT1 in combination with an electrophysiological study, which includes a nerve conduction study, to detect early diabetic peripheral neuropathy, before the appearance of clinical manifestations.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 5
Maximum Age: 10
Healthy Volunteers: t
View:

• Children with confirmed DT1 under insulin substitution therapy

• Age 5-10 years

• Good glycemic control with HbA1c ≤ 7.0%

• Prepubertal patients

• Absence of other diseases

• Signed informed consent of the parents or guardians of patients

Locations
Other Locations
Greece
Unit of Pediatric Endocrinology, Diabetes and Metabolism-2nd Department of Pediatrics, School of Medicine, Faculty of Health Sciences, Aristotle University of Thessaloniki
RECRUITING
Thessaloniki
Contact Information
Primary
Assimina Galli-Tsinopoulou, MD,PhD
agalli@auth.gr
+302310991537
Backup
Eleni Litou, MD
eleni.li.87@gmail.com
+302313323920
Time Frame
Start Date: 2018-11-20
Estimated Completion Date: 2025-01-20
Participants
Target number of participants: 50
Treatments
Diabetes type 1
Patients= diabetes type1
Healthy participants
Healthy participants = Control group
Sponsors
Leads: Aristotle University Of Thessaloniki

This content was sourced from clinicaltrials.gov